Praxis Precision Medicines, Inc. (PRAX) vs Protagonist Therapeutics, Inc. (PTGX)

Praxis Precision Medicines, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Protagonist Therapeutics, Inc. is the larger, with a market value of $8.9B against $7.9B — 1.1× the size. Praxis Precision Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 117×. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 34.8%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs 0.00%) and the higher return on invested capital (61.8% vs −40.6%). Across the 15 metrics below, Protagonist Therapeutics, Inc. leads on 11 and Praxis Precision Medicines, Inc. on 4.